Skip to main content
. 2023 Sep 29;102(39):e34693. doi: 10.1097/MD.0000000000034693

Figure 6.

Figure 6.

Central Illustration demonstrating the effects of SGLT2 inhibitors compared with placebo groups in HFpEF. HFpEF = heart failure with reduced ejection fraction, SGLT2 = Sodium-glucose co-transporter 2.